RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807917
DOI: 10.1055/s-0045-1807917
ONCO-HEMATOLOGY
1792
POSTER PRESENTATION
Daratumumab-based quadruplet therapy versus triplet consolidated therapy for the treatment of transplantation-eligible patients with multiple myeloma: a meta-analysis of randomized controlled trials
Authors
Publikationsverlauf
Artikel online veröffentlicht:
06. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Isabela Frazão Gonçalves, Alex Mota Cavalcante, Rodrigo Jeha Abdalah Daura, José Claudio Casali da Rocha. Daratumumab-based quadruplet therapy versus triplet consolidated therapy for the treatment of transplantation-eligible patients with multiple myeloma: a meta-analysis of randomized controlled trials. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807917
Isabela Frazão Gonçalves, Alex Mota Cavalcante, Rodrigo Jeha Abdalah Daura, José Claudio Casali da Rocha. Daratumumab-based quadruplet therapy versus triplet consolidated therapy for the treatment of transplantation-eligible patients with multiple myeloma: a meta-analysis of randomized controlled trials. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807917